Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

Market Cap	8.73B -11.6%
Revenue (ttm)	6.37B +8.0%
Net Income	523.98M +7.1%
EPS	0.20 +7.5%
Shares Out	n/a
PE Ratio	11.04
Forward PE	18.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	2.200
Previous Close	2.140
Day's Range	2.200 - 2.200
52-Week Range	1.932 - 2.860
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SFOSF

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, car...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 40,603
• Stock Exchange: OTCMKTS
• Ticker Symbol: SFOSF

Financial Performance

In 2025, SFOSF's revenue was 41.66 billion, an increase of 1.45% compared to the previous year's 41.07 billion. Earnings were 3.37 billion, an increase of 21.69%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error